EVENITY — Total revenues
Amgen EVENITY — Total revenues decreased by 6.2% to $562M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.1%, from $442M to $562M. Over 4 years (FY 2021 to FY 2025), EVENITY — Total revenues shows an upward trend with a 41.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market penetration, successful clinical adoption, or expanded patient access, while a decrease may signal increased competition, patent expiration, or shifts in clinical treatment guidelines.
Detailed definition
This metric represents the total gross sales generated from the commercialization of a specific bone-building therapeuti...
Peer comparison
Comparable to product-specific revenue lines for specialty pharmaceuticals or biologics in the osteoporosis or chronic disease treatment markets.
amgn_segment_evenity_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $132.5M | $132.5M | $132.5M | $170M | $191M | $201M | $225M | $254M | $281M | $307M | $318M | $342M | $391M | $399M | $431M | $442M | $518M | $541M | $599M | $562M |
| QoQ Change | — | +0.0% | +0.0% | +28.3% | +12.4% | +5.2% | +11.9% | +12.9% | +10.6% | +9.3% | +3.6% | +7.5% | +14.3% | +2.0% | +8.0% | +2.6% | +17.2% | +4.4% | +10.7% | -6.2% |
| YoY Change | — | — | — | — | +44.2% | +51.7% | +69.8% | +49.4% | +47.1% | +52.7% | +41.3% | +34.6% | +39.1% | +30.0% | +35.5% | +29.2% | +32.5% | +35.6% | +39.0% | +27.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's evenity — total revenues?
- Amgen (AMGN) reported evenity — total revenues of $562M in Q1 2026.
- How has Amgen's evenity — total revenues changed year-over-year?
- Amgen's evenity — total revenues increased by 27.1% year-over-year, from $442M to $562M.
- What is the long-term trend for Amgen's evenity — total revenues?
- Over 4 years (2021 to 2025), Amgen's evenity — total revenues has grown at a 41.1% compound annual growth rate (CAGR), from $530M to $2.1B.
- What does evenity — total revenues mean?
- The total revenue generated from the sales of a specific bone-building therapeutic product.